Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × dexamethasone 21-phosphate × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 9 Burkitt Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Biphenotypic, Acute 3 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Smoldering Multiple Myeloma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Fatigue 1 Down Syndrome 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Specimen Handling 2 Cyclophosphamide 2 Biopsy 2 tazemetostat 1 talimogene laherparepvec 1 fludarabine phosphate 1 fludarabine 1 belinostat 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 MEDI-570 1 Filgrastim 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡